Ustilaginoidea virens

From WikiMD's WELLNESSPEDIA

File:U.Virens.jpg
Ustilaginoidea virens spores on rice

Ustilaginoidea virens is a fungus that causes the disease known as false smut in rice plants. This pathogen is of significant concern in agriculture due to its impact on rice yield and quality.

Taxonomy[edit]

Ustilaginoidea virens belongs to the phylum Ascomycota, which is characterized by the formation of ascospores within asci. It is part of the class Sordariomycetes, order Hypocreales, and family Clavicipitaceae.

Morphology[edit]

The fungus produces distinctive spores that appear as yellowish-green balls on the rice panicle. These spore balls are actually sclerotia, which are hardened masses of fungal mycelium that can survive in the soil for extended periods.

Life Cycle[edit]

Ustilaginoidea virens has a complex life cycle that involves both sexual and asexual stages. The primary mode of infection is through conidia, which are asexual spores that infect the rice flowers. Once inside the host, the fungus colonizes the ovary and forms sclerotia.

Symptoms[edit]

Infected rice plants exhibit symptoms such as the presence of sclerotia on the panicles, which can lead to reduced grain quality and yield. The sclerotia are initially covered by a white fungal mass that turns yellowish-green as it matures.

Management[edit]

Management of Ustilaginoidea virens involves a combination of cultural practices, chemical control, and the use of resistant varieties. Cultural practices include crop rotation and the removal of infected plant debris to reduce the inoculum in the field.

Economic Impact[edit]

False smut caused by Ustilaginoidea virens can lead to significant economic losses in rice production. The disease affects both the quantity and quality of the rice grains, making them less marketable.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.